On April 29th, The Wall Street Journal reported that Pfizer’s Covid-19 pill has failed its latest test.
The article reports:
The Covid-19 pill from Pfizer Inc. failed to prevent symptomatic infections in adults who had been exposed to the pandemic virus, a late-stage study found.
Pfizer said Friday that the drug, named Paxlovid, failed the study’s main objective of meaningfully reducing the risk of confirmed and symptomatic Covid-19 infections in adults who were exposed to the virus by someone in their household.
Paxlovid was cleared for use in December by U.S. health regulators to treat people 12 years and older early in the course of their disease who are at high risk of developing severe Covid-19.
A website called uncoverdc.com reported the following:
Tennessee Governor Bill Lee signed a bill on Apr. 22, 2022, allowing Ivermectin to be dispensed without a prescription. The new law states, “a pharmacist, in good faith, may provide Ivermectin to a patient who is eighteen (18) years of age or older pursuant to a valid collaborative pharmacy practice agreement containing a non-patient-specific prescriptive order and standardized procedures developed and executed by one (1) or more authorized prescribers.”
Introduced by Sen. Frank Niceley (R-Strawberry Plains) on Jan. 31, Senate Bill 2188 was co-sponsored by Sen. Rusty Crowe (R-Johnson City). The amended version of the bill signed by Gov. Lee will create a standard procedure for pharmacists to easily dispense Ivermectin to patients while protecting a pharmacist or doctor from being held liable for doing so.
The article includes the following chart:
Ivermectin can cost up to $4 a day. As of April 2022, the cost of the Paxlovid treatment costs $530. I think it’s time to take a really good look at big pharma and its relationship to the FDA and related organizations. American medicine has prioritized profit over patient treatment and that needs to change.